Protein aggregation in silico

Trends in Biotechnology

Volumn 25, Issue 6, 2007, Pages 254-261

  Cellmer, Troy ^a   Bratko, Dusan ^b,c   Prausnitz, John M ^c,d   Blanch, Harvey W ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c University of California   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; BIOTECHNOLOGY; COMPUTATIONAL METHODS; COMPUTER SIMULATION; DRUG PRODUCTS; MOLECULAR DYNAMICS; PURIFICATION;

MOLECULAR SIMULATION; PROTEIN AGGREGATION; PROTEIN MISFOLDING; PROTEIN THERAPEUTICS;

PROTEINS;

AMYLOID;

AMINO ACID SEQUENCE; BIOTECHNOLOGY; COMPUTER MODEL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; STIMULATION;

BINDING SITES; COMPUTER SIMULATION; CRYSTALLIZATION; MODELS, CHEMICAL; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEINS; TEMPERATURE;

EID: 34248549336     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2007.03.011     Document Type: Review

References (65)

1. Frokjaer S., and Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4 (2005) 298-306
2. Chi E.Y., et al. Physical stability of proteins in aqueous solution: mechanism and driving forces in non-native protein aggregation. Pharm. Res. 20 (2003) 1325-1336
3. Clark E.D. Protein refolding for industrial processes. Curr. Opin. Biotechnol. 12 (2001) 202-207
4. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
5. Zhang S. Fabrication of novel biomaterials through molecular self-assembly. Nat. Biotechnol. 21 (2003) 1171-1178
6. Koga T., et al. Controlled self-assembly of amphiphilic oligopeptides into shape-specific nanoarchitectures. Chemistry 12 (2006) 1360-1367
7. Head-Gordon T., and Brown S. Minimalist models for protein folding and design. Curr. Opin. Struct. Biol. 13 (2003) 160-167
8. Dokholyan N.V. Studies of folding and misfolding using simplified models. Curr. Opin. Struct. Biol. 16 (2006) 79-85
9. Dinner A.R., et al. Understanding protein folding via free-energy surfaces from theory and experiment. Trends Biochem. Sci. 25 (2000) 331-339
10. Dill K.A., and Chan H.S. From Levinthal to pathways to funnels. Nat. Struct. Biol. 4 (1997) 10-19
11. Bratko D., et al. Effect of single-point sequence alterations on the aggregation propensity of a model protein. J. Am. Chem. Soc. 128 (2006) 1683-1691
12. Cellmer T., et al. Thermodynamics of folding and association of lattice-model proteins. J. Chem. Phys. 122 (2005) 174908
13. Cellmer T., et al. Protein-folding landscapes in multichain systems. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11692-11697
14. Wolynes P.G. Energy landscapes and solved protein-folding problems. Philos Transact A Math Phys. Eng. Sci. 363 (2005) 453-464
15. Gupta P., et al. Effect of denaturant and protein concentrations upon protein refolding and aggregation: a simple lattice model. Protein Sci. 7 (1998) 2642-2652
16. De Bernardez Clark E., et al. Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation. Biotechnol. Prog. 14 (1998) 47-54
17. Nguyen H.D., and Hall C.K. Effect of rate of chemical or thermal renaturation on refolding and aggregation of a simple lattice protein. Biotechnol. Bioeng. 80 (2002) 823-834
18. Cellmer T., et al. The competiton between protein folding and aggregation: off-lattice minimalist model studies. Biotechnol. Bioeng. 89 (2005) 78-87
19. Honeycutt J.D., and Thirumalai D. The nature of folded states of globular proteins. Biopolymers 32 (1992) 695-709
20. Bratko D., and Blanch H.W. Competition between protein folding and aggregation: a three-dimensional lattice-model simulation. J. Chem. Phys. 114 (2001) 561-569
21. Lu D., and Liu Z. Molecular simulation of polymer-assisted protein refolding. J. Chem. Phys. 123 (2005) 134903
22. Voigt C.A., et al. Computationally focusing the directed evolution of proteins. J Cell Biochem Suppl 37 (2001) 58-63
23. Johannes T.W., and Zhao H. Directed evolution of enzymes and biosynthetic pathways. Curr. Opin. Microbiol. 9 (2006) 261-267
24. Eijsink V.G., et al. Rational engineering of enzyme stability. J. Biotechnol. 113 (2004) 105-120
25. Ding F., et al. Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. J. Mol. Biol. 324 (2002) 851-857
26. Clark L. Protein aggregation determinants from a simplified model - cooperative folders resist aggregation. Protein Sci. 14 (2005) 653-662
27. Janowski R., et al. 3D domain-swapped human cystatin C with amyloid-like intermolecular beta-sheets. Proteins 61 (2005) 570-578
28. Bennett M.J., et al. Deposition diseases and 3D domain swapping. Structure 14 (2006) 811-824
29. Chen Y., and Dokholyan N.V. A single disulfide bond differentiates aggregation pathways of β2-microglobulin. J. Mol. Biol. 354 (2005) 473-482
30. Istrail S., et al. Lattice simulations of aggregation funnels for protein folding. J. Comput. Biol. 6 (1999) 143-162
31. Schwartz R., et al. Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues. Protein Sci. 10 (2001) 1023-1031
32. Chiti F., et al. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9 (2002) 137-143
33. Pawar A.P., et al. Prediction of aggregation-prone and 'aggregation-susceptible' regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 350 (2005) 379-392
34. Chiti F., et al. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (2003) 805-808
35. Fowler S.B., et al. Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10105-10110
36. Fernandez-Escamilla A.M., et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
37. Thirumalai D., et al. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 13 (2003) 146-159
38. Uversky V.N., et al. Why are 'natively unfolded' proteins unstructured under physiologic conditions?. Proteins 41 (2000) 415-427
39. Otzen D.E., et al. Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9907-9912
40. Richardson J.S., and Richardson D.C. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2754-2759
41. Wang W.X., and Hecht M.H. Rationally designed mutations convert de novo amyloid-like fibrils into monomeric β-sheet proteins. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2760-2765
42. Fawzi N.L., et al. Influence of denatured and intermediate states of folding on protein aggregation. Protein Sci. 14 (2005) 993-1003
43. Villegas V., et al. Protein engineering as a strategy to avoid formation of amyloid fibrils. Protein Sci. 1700 (2000) 1700-1708
44. Fink A.L. Protein aggregation: folding aggregates, inclusion bodies, and amyloid. Fold. Des. 3 (1998) R9-R23
45. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
46. Bernstein S.L., et al. Amyloid β-protein: monomer structure and early aggregation states of Aβ42 and its Pro19 alloform. J. Am. Chem. Soc. 127 (2005) 2075-2084
47. Baumketner A., et al. Structure of the 21-30 fragment of amyloid β-protein. Protein Sci. 15 (2006) 1239-1247
48. Baumketner A., et al. Amyloid β-protein monomer structure: a computational and experimental study. Protein Sci. 15 (2006) 420-428
49. Ma B., and Nussinov R. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ 16-22, Aβ 16-35, and Aβ 10-35): sequence effects. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14126-14131
50. Ma B., and Nussinov R. Molecular dynamics simulations of alanine-rich β-sheet oligomers: insight into amyloid formation. Protein Sci. 11 (2002) 2335-2350
51. Armen R.S., et al. Characterization of a possible amyloidogenic precursor in glutamine-repeat neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13433-13438
52. Armen R.S., et al. Pauling and Corey's alpha pleated-sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11622-11627
53. Armen R.S., et al. Anatomy of an amyloidogenic intermediate: conversion of β-sheet to α-sheet structure in transthyretin at acidic pH. Structure 12 (2004) 1847-1863
54. Nguyen H.D., and Hall C.K. Spontaneous fibril formation by polyalanines; discontinuous molecular dynamics simulations. J. Am. Chem. Soc. 128 (2006) 1890-1901
55. Nguyen H.D., and Hall C.K. Phase diagrams describing fibrillization by polyalanine peptides. Biophys. J. 87 (2004) 4122-4134
56. Nguyen H.D., and Hall C.K. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16180-16185
57. Nguyen H.D., and Hall C.K. Kinetics of fibril formation by polyalanine peptides. J. Biol. Chem. 280 (2005) 9074-9082
58. Serio T.R., et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289 (2000) 1317-1321
59. Cheung M.S., et al. Molecular crowding enhances native state stability and refolding rates of globular proteins. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4753-4758
60. Anderson R.E., et al. Dynamic lattice Monte Carlo simulation of a model protein at an oil/water interface. J. Chem. Phys. 112 (2000) 9167-9185
61. Urbanc B., et al. Molecular dynamics simulation of amyloid beta dimer formation. Biophys. J. 87 (2004) 2310-2321
62. Khare S.D., et al. Molecular origin of polyglutamine aggregation in neurodegenerative diseases. PLoS Comput Biol 1 (2005) 230-235
63. Ding F., et al. Direct observation of protein folding, aggregation, and a prion-like conformational conversion. J. Biol. Chem. 280 (2005) 40235-40240
64. Urbanc B., et al. In silico study of amyloid β-protein folding and oligomerization. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17345-17350
65. Khare S.D., et al. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15094-15099